Oxford-AstraZeneca coronavirus vaccine 90% kamyaab

London:  November 24, 2020. AstraZeneca para koishe ke, novel coronavirus nemite University of Oxford logot melikena bona vaccine toh 70% virus ke pachabo parai koikena tuita(2) study te kamyaab hoishe. Oxford University para press khobor te koishe ke, “Phase 3 interim analysis pithor te 131 Covid-19 cases te vaccine toh 70.4% safe paishe”. Company para press release te kowa toh, “UK aro Brazil te AZD1222 laga clinical trials te Positive high-level khobor paishe aro etu vaccine toh COVID-19 nemite besi bhal para pachabo”. “ekta tawai lowa te result toh ketai AZD1222 toh atha tawai loishe 90% safe thikaishe, etu beche te pura tawai toh 1 moina beche te lobo. Tuita(2) wala tawai para 62% safe thikaishe aro pura toh moina beche loboli koishe. Melaikena hesab kora te average toh 70% safe olaishe:” koishe. Etu data toh komti low ate manuh logot novel coronavirus, SARS-COV2 para pachabo. Company para koishe ke, data toh othai thakibo arp etu oper te test toh jai thakibo, etu para pachaikena thaka sin toh hesab koribo. “etu vaccine bhal aro safe ase koikena jana para COVID-19 kelaff te public health emergency te tangor motob pabo. Etu oper te, vaccine’s simple supply hoboli aro laap nathaka toh board para  wada thishe arp duniyaa pura te manuh sob logot million tawai toh mania beche paijaboli koishe, etu khobor toh AstraZeneca chief executive officer, Pascal Soriot para janai thishe. Dosura tuita(2) Pfizer aro Moderna, para etu hafta pithor te tai khan laga late-stage trials toh 95% safe aro bhal ase janaikena ase. Pfizer para bona coronavirus vaccine toh late-stage trial samai 95 per cent safe thikaishe, koikena company para jaa hafta koishe.